Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.91 +0.03 (+3.03%)
As of: Oct 1, 2026 · 3:16 PM EDT

Alaunos Therapeutics (TCRT) Gross Margin (2011)

Updated

Alaunos Therapeutics (TCRT) posted Gross Margin of -5233.50% for Q3 2011, down 771.00 percentage points from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Gross Margin (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 68.19%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 74.74%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 78.02%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 83.60%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 72.04%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 79.76%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 85.33%
10 Alaunos Therapeutics 2.19 Mn -1.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 -5,233.50%
Jun 30, 2011 -4,462.50%
API Access

Alaunos Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=TCRT&period=max&api_key=YOUR_API_KEY